<DOC>
	<DOCNO>NCT00797342</DOCNO>
	<brief_summary>This study evaluate safety , tolerability , pharmacokinetics pharmacodynamics PF-04629991 healthy subject . Dose exploration proceed step-wise manner , begin low dos expect significant biological effect proceed dos approximate exceed anticipate therapeutic level . Doses explore may limited tolerability , exceed level previously show tolerable animal .</brief_summary>
	<brief_title>A Study Safety , Tolerability , Pharmacokinetics Pharmacodynamics PF-04629991 Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy nonsmoking men woman body mass index 1830 kg/m2 Women must able child current infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>rheumatoid arthritis First human safety pharmacokinetics pharmacodynamics</keyword>
</DOC>